Is Delta-8-THC legal in Guyana?

Legal status

Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «delta-8-tetrahidrocannabinol», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry names the delta-8 positional isomer specifically. That is what makes this row separable from the generic cannabis entry and from delta-9 tetrahydrocannabinol, and a product sold as hemp derived does not escape a named isomer entry by being derived from hemp. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.

Consequences if caught

Capital exposure: none. Guyana's Cap. 10:10 carries no death penalty at any tier; section 5(1) sets the indictable trafficking ceiling at life imprisonment, so the worst outcome this Act reaches is a life sentence. No per-substance number is printed for this row, so the schedule supplies the placement and section 5(1) supplies the ceiling: there is no weight band, no tariff and no quantity threshold attached to «delta-8-tetrahidrocannabinol» itself. Isomer identification is the whole evidential question here, because the analytical difference between the two isomers is small and the schedule treats the named one on its own terms. What the ceiling does not do is say where inside it a case lands, and the dossier records no sentencing range, no minimum and no fine figure for this row.

If prescribed or medical

Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «delta-8-tetrahidrocannabinol» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Delta-8 products are sold as consumer goods rather than dispensed, so a prescription is not the route and no authorisation is recorded. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.

Documentation

A certificate of analysis naming the isomer is the only document that speaks to this entry, and it is evidence of contents rather than permission to carry them. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «delta-8-tetrahidrocannabinol».

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Guyana’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.